SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-306463
Filing Date
2018-10-24
Accepted
2018-10-24 16:59:59
Documents
5
Period of Report
2018-10-18
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d635978d8k.htm 8-K 25088
2 EX-10.1 d635978dex101.htm EX-10.1 137070
3 EX-10.2 d635978dex102.htm EX-10.2 6438
4 EX-99.1 d635978dex991.htm EX-99.1 14696
5 GRAPHIC g635978g42n08.gif GRAPHIC 3748
  Complete submission text file 0001193125-18-306463.txt   190031
Mailing Address 300 GEORGE STREET SUITE 301 NEW HAVEN CT 06511
Business Address 300 GEORGE STREET SUITE 301 NEW HAVEN CT 06511 312 767 0291
MELINTA THERAPEUTICS, INC. /NEW/ (Filer) CIK: 0001461993 (see all company filings)

IRS No.: 454440364 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35405 | Film No.: 181136921
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences